Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

This study has been terminated.
(Due to financial reasons)
Information provided by (Responsible Party):
Neurologix, Inc. Identifier:
First received: March 24, 2008
Last updated: February 20, 2012
Last verified: February 2012